Trizivir - Abacavir, lamivudine, and zidovudine (Trizivir) is an antiviral medication. It is in a group of human immunodeficiency virus (HIV) medicines called reverse transcriptase inhibitors. This medication helps keep the HIV virus from reproducing in the body.
This medication is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). This medication is not a cure for HIV or AIDS.
This medication may also be used for other purposes not listed in this medication guide. This medication should not be given to people who weigh less than 90 pounds.
Used for: Treating HIV infection. Trizivir is used alone or in combination with other medicines.
Trizivir is a nucleoside reverse transcriptase inhibitor (NRTI) combination. It works by blocking HIV from reproducing.
This medicine contains 3 different types of anti-viral medicines: 1. Trizivir 2. Lamivudine (also known as 3TC) 3. Zidovudine Abacavir+Lamivudine+Zidovudine is used together with other anti-viral medications to treat Human Immunodeficiency Virus (HIV) infection. HIV infection can lead to Acquired Immune Deficiency Syndrome (AIDS). This medicine is used to treat HIV infection in adults and children. This medicine is not a cure for HIV. It only helps to keep the virus in check and can help improve the quality of life. It does not prevent the spread of HIV to other people.
Alone or in combination with other antiretroviral agents for the treatment of HIV-1 infection. The indication for Trizivir is based on 2 controlled trials with Trizivir of 16 and 48 weeks in duration that evaluated suppression of HIV RNA and changes in CD4 cell count. At present, there are no results from controlled trials evaluating the effect of Trizivir on clinical progression of HIV. There are limited data on the use of this triple combination regimen in patients with higher viral load levels (>100,000 copies/mL) at baseline (see
Pharmacology: Clinical Studies under Actions).
Indications: hiv infection
This medicine is indicated for the treatment of human immunodeficiency virus (HIV-1) infection.
Trizivir is indicated in combination with other antiretrovirals or alone for the treatment of HIV-1 infection. Additional important information on the use of Trizivir for treatment of HIV-1 infection: • Trizivir is one of multiple products containing abacavir. Before starting TRIZIVIR, review medical history for prior exposure to any abacavir-containing product in order to avoid reintroduction in a patient with a history of hypersensitivity to abacavir. • Limited data exist on the use of Trizivir alone in patients with higher baseline viral load levels (>100,000 copies/mL).
Antiretroviral therapy for the treatment of HIV-infected adults and adolescents >12 years.